[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352952-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352952-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-potential-of-atf5-as-a-prognostic-marker-and-therapeutic-target-in-cancer-insights-from-bioinformatics-analysis-and-experimental-validation","The potential of ATF5 as a prognostic marker and therapeutic target in cancer - insights from bioinformatics analysis and experimental validation","","Activating transcription factor 5 (ATF5) functions as a transcription regulator linked to cancer biology. A comprehensive pan-cancer bioinformatics workflow evaluates ATF5 expression, its association with patient prognosis and tumor staging, and related immunological features. Protein interaction and co-expression enrichment analyses suggest roles in tumor proliferation, differentiation, and apoptosis, with glioma-focused validation using flow cytometry, immunohistochemistry, and in vitro phase-separation/aggregation assays. ATF5 knockdown enhances glioma apoptosis and ATF5 aggregation is modulated by factors such as salt concentration, supporting ATF5 as a prognostic and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-potential-of-atf5-as-a-prognostic-marker-and-therapeutic-target-in-cancer-insights-from-bioinformatics-analysis-and-experimental-validation/352952/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-potential-of-atf5-as-a-prognostic-marker-and-therapeutic-target-in-cancer-insights-from-bioinformatics-analysis-and-experimental-validation/352952.png","ImageObject",300,407,{"name":42,"@type":43},"Cipher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was ATF5 evaluated across different cancers in this study?","Question",{"text":63,"@type":64},"ATF5 expression was analyzed using systematic bioinformatics across multiple tumor types, followed by correlation testing with patient prognosis, tumor staging, and immunological characteristics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What evidence links ATF5 to glioma progression and grade?",{"text":68,"@type":64},"Immunohistochemistry demonstrated a strong association between ATF5 expression and glioma pathological grades, and ATF5 expression correlated with outcomes in glioma-related analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"Does reducing ATF5 affect glioma cell apoptosis?",{"text":72,"@type":64},"Yes. Flow cytometry showed that interfering with ATF5 expression using small interfering RNA (siRNA) promoted apoptosis in glioma cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352952,1790613664,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Article  \nThe potential of ATF5 as a prognostic marker and therapeutic target in cancer: insights from bioinformatics analysis and experimental validation  \nYanrong Zhao1\\#^, Hongyu Yang1\\#^, Tingting Cai1^, Zhizhong Hao1^, Qingju Sun2^, Dongmeng Qian1^, Ming Hu1^  \n1Department of Special Medicine, School of Basic Medicine, Qingdao University, Qingdao, China; 2Department of Clinical Laboratory, Navy No.  \n971 Hospital, Qingdao, China  \nContributions: (I) Conception and design: Y Zhao, H Yang, M Hu; (II) Administrative support: M Hu; (III) Provision of study materials or patients: M Hu, Q Sun; (IV) Collection and assembly of data: Y Zhao, H Yang, T Cai, Z Hao; (V) Data analysis and interpretation: Y Zhao, H Yang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Ming Hu, PhD. Department of Special Medicine, School of Basic Medicine, Qingdao University, 308 Ningxia Road, Qingdao  \n266071, China. Email: [qdhm@qdu.edu.cn](qdhm@qdu.edu.cn).  \nBackground: Activating transcription factor 5 (ATF5) is a transcription regulator closely associated with cancers. Our previous studies have identified the expression and function of ATF5 in various malignant tumors. However, a comprehensive study of ATF5 remains lacking across different tumor types. This study will focus on a comprehensive analysis of ATF5 across various cancers, while further investigating the  \nfunction ofthe ATF5 protein in gliomas and its protein characteristics.  \nMethods: We investigated ATF5 expression across various tumors using systematic bioinformatics analysis. We further examined the correlations between ATF5 expression and patient prognosis, tumor staging, and immunological characteristics. Additionally, functional enrichment analysis was performed on proteins interacting with or co-expressed with ATF5 . We employed flow cytometry to analyze apoptosis and investigate the function of ATF5 in glioma cell lines. Furthermore, immunohistochemistry (IHC) was employed to validate the relationship between ATF5 expression and distinct glioma grades. Finally, we  \nexplored the protein phase-separation capacity of ATF5 and its influencing factors in vitro.  \nResults: ATF5 expression levels exhibited a strong correlation with prognosis in multiple cancers.  \nFunctional clustering analysis of the proteins interacting with ATF5 and co-expressed with ATF5 suggested that ATF5 might influence tumor cell proliferation, differentiation, and apoptosis. Immunohistochemical results demonstrated a strong association between ATF5 expression and glioma pathological grades.  \nAdditionally, flow cytometry analysis showed that interfering with ATF5 expression using small interfering RNA (siRNA) promoted apoptosis in glioma cells. Interestingly, droplet formation experiments confirmed  \nthat ATF5 is capable of aggregation in vitro and is influenced by factors such as salt concentration.  \nConclusions: Our findings indicate that ATF5 has prognostic value in cancer treatment, providing a  \npotential therapeutic target for subsequent treatment of related cancers.  \nKeywords: Activating transcription factor 5 (ATF5); pan-cancer; immune infiltration; apoptosis; prognosis  \nSubmitted Jan 15, 2026. Accepted for publication Mar 24, 2026. Published online Apr 28, 2026.  \ndoi: 10.21037/tcr-2026-1-0146  \nView this article at: [https://dx.doi.org/10.21037/tcr-2026-1-0146](https://dx.doi.org/10.21037/tcr-2026-1-0146)  \n^ ORCID: Yanrong Zhao, 0009-0004-4450-0573; Hongyu Yang, 0009-0000-7517-3983; Tingting Cai, 0009-0002-1478-3504; Zhizhong Hao, 0009-0005-6759-6501; Qingju Sun, 0009-0006-9824-9585; Dongmeng Qian, 0009-0006-9824-9585; Ming Hu, 0000-0001-6858-7088.  \n© AME Publishing Company. Transl Cancer Res 2026;15(4):326 | [https://dx.doi.org/10.21037/tcr-2026-1-0146](https://dx.doi.org/10.21037/tcr-2026-1-0146)  \nPage 2 of 18 Zhao et al. ATF5 as a prognostic marker and therapeutic targe","cbCaicBa0daRT6bo","https://ap.wps.com/l/cbCaicBa0daRT6bo","pdf",5229180,18,"English","# Introduction\n## Methods\n## Results\n## Conclusions\n## Highlight box\n### Key findings\n### What is known and what is new?","[{\"question\":\"How was ATF5 evaluated across different cancers in this study?\",\"answer\":\"ATF5 expression was analyzed using systematic bioinformatics across multiple tumor types, followed by correlation testing with patient prognosis, tumor staging, and immunological characteristics.\"},{\"question\":\"What evidence links ATF5 to glioma progression and grade?\",\"answer\":\"Immunohistochemistry demonstrated a strong association between ATF5 expression and glioma pathological grades, and ATF5 expression correlated with outcomes in glioma-related analyses.\"},{\"question\":\"Does reducing ATF5 affect glioma cell apoptosis?\",\"answer\":\"Yes. Flow cytometry showed that interfering with ATF5 expression using small interfering RNA (siRNA) promoted apoptosis in glioma cells.\"}]","The potential of ATF5 as a prognostic marker and therapeutic target in cancer - insights from bioinformatics analysis and experimental validation | PDF",1790102290,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cfbf6d206836b3b095200fdc951a684.webp",983,1287,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27966e9071c35fdc04502752c11c5ca6.webp",982,1286,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065c5de6de9dde075c97fb641639d339.webp",981,1284,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fb9dc717f7479a9c13853b3cbb99931.webp",980,1283]